Nov. 13, 2020 | 11:00 AM - 12:30 PM CST
Accelerating time-to-market equals a greater return on innovation for most organizations. In the new norm, where most employees are distributed, organizations strive to maintain security standards while providing employees access to essential resources to maintain the pace of innovation. In the Pharmaceutical industry, protecting intellectual property is paramount but so is the need to support remote working and seamless access to network resources. Yet, extending greater access to home workers, exposes critical applications and information to untrusted devices and networks. During this Digital Boardroom discussion, we'll examine the impact of work-from-home on the security strategies used by Pharmaceutical organizations including moving to cloud-based solutions.
The goals of this session: